top of page
Browse by category
Search
Coffee time with Mr Abuchi Okaro
Bariatric News spoke to the current President of Bariatric, Metabolic Surgeons Society of Nigeria (BMSSN), Mr Abuchi Okaro (a consultant...
MyPhenome test can predict future weight gain
Phenomix Sciences has announced the findings from new research conducted at Mayo Clinic and presented at ObesityWeek 2024, which...
GLP-1 RAs show cardiovascular benefits beyond weight loss
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) continue to show cardiovascular benefits beyond weight loss, according to several...
GLP-1 RAs may be effective in helping people drink less alcohol
A study led by researchers at the University of Nottingham has found that glucagon-like peptide-1 receptor agonists use (GLP-1 RAs) may...
260 million people in the US predicted to be living with overweight or obesity by 2050
The total number of US children and adolescents with overweight and obesity is expected to reach 43.1 million by 2050 (an additional 6.74...
ABS and AOBS agree Focused Practice Designation for metabolic and bariatric surgery examination
The American Board of Surgery (ABS) and the American Osteopathic Board of Surgery (AOBS) have announced a collaborative initiative to...
Gastric pouch resizing for recurrent weight gain promotes weight stabilisation in well-selected patients
Gastric pouch resizing (GPR) for recurrent weight gain after primary RYGB is a safe procedure promoting weight stabilisation or even mild...
COVID-19 pandemic: Bariatric surgery patients showed an increase in the percentage of weight regain
Two years after the start of the COVID-19 pandemic, bariatric surgery patients showed an increase in the percentage of weight regain and...
Semaglutide and liraglutide may reduce alcohol consumption in individuals with AUD
A joint study by the University of Eastern Finland and Karolinska Institutet in Sweden has found that the GLP-1 agonists semaglutide and...
NK2R burns energy and lowers appetite without the nausea and vomiting
Scientists at the University of Copenhagen have discovered a new weight loss drug target, neurokinin 2 receptor (NK2R), that reduces...
Browse by tag
bottom of page